Ethical considerations regarding the administration of oseltamivir for infection control indications [2]

Clinical Infectious Diseases

Volumn 45, Issue 1, 2007, Pages 133-134

  Collins, Cathal ^a   Drew, Richard ^a   Cormican, Martin ^b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ANTIVIRAL THERAPY; COMMUNITY ACQUIRED PNEUMONIA; DRUG INDICATION; DRUG TOLERABILITY; EARLY INTERVENTION; ETHICS; GASTROINTESTINAL SYMPTOM; HEALTH CARE PERSONNEL; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFLUENZA; INFORMED CONSENT; LETTER; MENTAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS;

EID: 34250853396     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518703     Document Type: Letter

References (2)

1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: S27-72.
2. Roche Laboratories. Tamiflu - prescribing information. Available at: http://www.fda.gov/medwatch/safety/2006/Tamiflu_PI.pdf. Accessed 11 February 2007.